X37
0 followers
X-37 has closed a $14.5 million Series A financing, led by DCVC Bio and joined by Alpha Intelligence Capital and Hemi Ventures. X-37 was cofounded by AtomWise and an experienced team of pharmaceutical developers from Velocity Pharmaceutical Development. With AtomWise’s top #AI platform, we have alre... Read more
Org chart
David Collier
CEO & Board Member
David Collier
Collapse
Matthew Kerby
Head of Lead Discovery
James Larrick
Head of Target Identification
Andrew Pearlman
Head of Non-Clinical Development
Anie Roche
General Counsel
Ed Schnipper
Head of Clinical Development
